Press ReleasesUpstream Tech and Carahsoft Partner to Bring Land, Water Management Software to Public Sector

June 10, 2025

Upstream Tech and Carahsoft Partner to Bring Land, Water Management Software to Public Sector

Efficient, Science-Backed Software Now Available to Government Agencies

Efficient, Science-Backed Software Now Available to Government Agencies

Source: https://www.globenewswire.com/news-release/2025/06/10/3097004/0/en/Upstream-Tech-and-Carahsoft-Partner-to-Bring-Land-Water-Management-Software-to-Public-Sector.html

$Results from Phase 1/2 Study of Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology$

Results from Phase 1/2 Study of Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology

Michael Baker International Strengthens Market Position with Infinity Rebranding

globenewswire

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

Upstream Tech and Carahsoft Partner to Bring Land, Water Management Software to Public Sector

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

First AML expands Tranche 2 leadership in Australia following major client wins across law and real estate

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

Lake Chelan Health enters into Prime Vendor agreement with Medline

Recent News

First AML expands Tranche 2 leadership in Australia following major client wins across law and real estate

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

Explore

Press Releases

News & Opinion

Living

Others

Follow us

מועד אחרון לתביעה נגד BBAI: רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי BigBear.ai Holdings,...

Xometry Announces Convertible Debt Refinancing and Closing of $250 Million of 0.75% Convertible Senior...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation...